From: Gene expression of sternohyoid and diaphragm muscles in type 2 diabetic rats
GO group category & specific GO term | Diaphragm # genes | P value | Sternohyoid # genes | P value |
---|---|---|---|---|
Metbolism - Lipid | Â | Â | Â | Â |
Lipid metabolic process | 9 | 0.019 | 10 | 0.012 |
Long-chain fatty acid transport | 2 | 0.048 | 3 | 0.0012 |
Cellular lipid metabolic process | Â | Â | 9 | 0.010 |
Fatty acid metabolic process | Â | Â | 6 | 0.0030 |
Lipid transport | Â | Â | 4 | 0.0077 |
Fatty acid transport | Â | Â | 3 | 0.0021 |
Metabolism - Carbohydrate | Â | Â | Â | Â |
Carbohydrate metabolic process | 7 | 0.040 | Â | Â |
Monosaccharide metabolic process | 6 | 0.0037 | Â | Â |
Hexose metabolic process | 6 | 0.0036 | Â | Â |
Cellular carbohydrate metabolic process | 6 | 0.034 | Â | Â |
Carbohydrate biosynthetic process | 4 | 0.016 | Â | Â |
Glycerol-3-phosphate dehydrogenase complex | Â | Â | 2 | 0.018 |
Glycerol-3-phosphate dehydrogenase activity | Â | Â | 2 | 0.012 |
Muscle contraction | Â | Â | Â | Â |
Sarcomere | 4 | 0.0066 | Â | Â |
Myofibril | 4 | 0.010 | Â | Â |
Contractile fiber part | 4 | 0.010 | Â | Â |
Contractile fiber | 4 | 0.014 | Â | Â |
Striated muscle contraction | 3 | 0.014 | Â | Â |
Muscle system process | Â | Â | 6 | 0.0017 |
Muscle contraction | Â | Â | 6 | 0.0015 |
Regulation of muscle contraction | Â | Â | 4 | 0.0022 |
Ion transport | Â | Â | Â | Â |
Ion transport | 12 | 0.0015 | 11 | 0.0089 |
Calcium ion binding | 9 | 0.024 | 12 | 0.0033 |
Inorganic anion transport | 5 | 0.0072 | 5 | 0.010 |
Anion transport | 5 | 0.015 | 6 | 0.0037 |
Regulation of ion transport | 3 | 0.014 | Â | Â |
Channel activity | 6 | 0.031 | Â | Â |
Magnesium ion binding | Â | Â | 5 | 0.037 |
Collagen | Â | Â | Â | Â |
Fibrillar collagen | 3 | 0.0015 | 3 | 0.0016 |
Collagen | 3 | 0.018 | 4 | 0.0012 |
Collagen type I | 2 | 0.013 | 2 | 0.012 |
Blood circulation | Â | Â | Â | Â |
Blood circulation | 5 | 0.016 | Â | Â |
Circulatory system process | 5 | 0.017 | Â | Â |
Oxidoreductase activity | ||||
Oxidoreductase activity | 10 | 0.035 | Â | Â |
Immune & inflammatory | ||||
Immune system process | Â | Â | 10 | 0.013 |
Immune response | Â | Â | 9 | 0.0033 |
Defense response | Â | Â | 8 | 0.0067 |
Immune effector process | Â | Â | 6 | 0.000076 |
Acute inflammatory response | Â | Â | 6 | 0.000027 |
Regulation of immune system process | Â | Â | 6 | 0.000036 |
Inflammatory response | Â | Â | 6 | 0.0082 |
Humoral immune response | Â | Â | 6 | 7.5E-06 |
Regulation of immune response | Â | Â | 6 | 0.000027 |
Activation of immune response | Â | Â | 5 | 0.000070 |
Positive regulation of immune system process | Â | Â | 5 | 0.00016 |
Complement activation | Â | Â | 5 | 0.000014 |
Positive regulation of immune response | Â | Â | 5 | 0.00013 |
Innate immune response | Â | Â | 5 | 0.00025 |
Adaptive immune response | Â | Â | 4 | 0.0062 |
Leukocyte mediated immunity | Â | Â | 4 | 0.0071 |
Lymphocyte mediated immunity | Â | Â | 4 | 0.0048 |
Adaptive immune response | Â | Â | 4 | 0.0057 |
B cell mediated immunity | Â | Â | 4 | 0.0032 |
Humoral immune response immunoglobulin | Â | Â | 3 | 0.0064 |
Complement activation-classical pathway | Â | Â | 3 | 0.0064 |
Complement component C1 complex | Â | Â | 2 | 0.012 |
Response to stress & wounding | ||||
Response to stress | Â | Â | 17 | 0.000096 |
Response to wounding | Â | Â | 7 | 0.023 |